Home/Topics/Companies & Institutions/Beam Therapeutics

🏢Organization Dossier

Beam Therapeutics

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

12 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Startups & Venture Capital Just now (02:02 PM IST)

Beam Therapeutics Sues Chinese Biotech and VC-Backed Startup Over Alleged IP Theft

Beam Therapeutics has filed suit against a Chinese biotech company and a venture-capital-backed startup, alleging theft of intellectual property tied to its gene-editing technology, according to STAT. The case adds to mounting tensions over biotech innovation, cross-border technology transfer, and the protection of proprietary research in a sector where patents and trade secrets are central to valuation.

By RDU Global Wire6 min read

Clean Energy & Climate Transition05 Nov 2026, 02:00 PM IST

Fingernail-Sized Photonic Chip Separates Mixed Light Into Clean Beams, Opening New Paths for Imaging and Energy-Efficient Optics

Researchers have demonstrated a fingernail-sized photonic chip that can untangle mixed light into distinct, mutually incoherent beams on chip, a capability that could improve imaging, optical communications, and future computing systems. The advance, reported in Nature and highlighted by Phys.org and related outlets, points to a compact way of controlling light with far greater precision than conventional bulky optical hardware.

6 min readRead →

Frontier AI & Machine Learning04 Nov 2026, 08:00 PM IST

Orbital Matter Prints First Rigid Beam in Space, Opening a New Path for Orbital Infrastructure

Orbital Matter has reported a first-of-its-kind manufacturing milestone: producing a rigid beam in the vacuum of space using 3D printing. The achievement is more than a technical curiosity; it points to a future in which large structures, including orbital data centers and other space infrastructure, could be assembled in orbit rather than launched fully built from Earth.

5 min readRead →

Clean Energy & Climate Transition04 Nov 2026, 08:00 PM IST

Stanford-Linked Chip Separates Mixed Light Into Clean Beams, Opening a New Path for Photonics

Researchers have demonstrated a fingernail-sized optical chip that can untangle partially coherent light into its separate components, a capability that could sharpen imaging and improve the efficiency of optical systems. The advance points to a new class of compact photonic hardware that may support cleaner signal processing for computing, sensing and communications.

5 min readRead →

Clean Energy & Climate Transition27 Oct 2026, 08:00 PM IST

A Laser Beam Reaches the Moon in Just Over One Second, But the Physics Behind It Matters Far More

A laser beam aimed from Earth to the Moon takes a little more than one second to arrive, a deceptively simple fact that underscores the precision of modern space science. The timing is not just a curiosity: it is central to lunar ranging, satellite navigation, and the measurement of Earth-Moon distance with extraordinary accuracy.

5 min readRead →

Clean Energy & Climate Transition27 Oct 2026, 08:00 AM IST

A Laser Beam Reaches the Moon in Just Over One Second, Revealing the Precision Behind Deep-Space Measurement

A laser beam aimed at the Moon takes roughly 1.3 seconds to arrive, a deceptively simple fact that underpins some of the most precise measurements in modern science. The timing is central to lunar ranging experiments, which help researchers test gravity, refine Earth-Moon distance data, and support future space navigation.

5 min readRead →

Global Markets & Equities07 Oct 2026, 12:30 AM IST

Beam Puts a New U.S. Open-Weight AI Challenger on the Map

Reflection AI has unveiled Beam, its first open-weight model, intensifying the race to build a credible American alternative to China’s fast-moving open AI ecosystem. The launch has drawn attention because it arrives as investors, enterprise buyers and policymakers increasingly view open models as a strategic layer in the global AI stack.

4 min readRead →

Global Markets & Equities25 Oct 2026, 08:00 AM IST

Tango Reports 82% Tumor Response in Pancreatic Cancer Trial, Raising the Stakes in a Crowded Race

Tango Therapeutics said its combination therapy produced an 82% tumor response rate in an early-stage trial involving advanced pancreatic cancer, a result that could sharpen investor attention on one of oncology’s most difficult targets. The data add momentum to the company’s strategy, while also inviting scrutiny over durability, patient selection and whether the response can translate into a meaningful late-stage commercial opportunity.

5 min readRead →

Global Health & Biotech06 Oct 2026, 08:29 AM IST

AstraZeneca CEO Says Summit Drug Could Anchor Next Wave of Cancer Combinations After $2 Billion Bet

AstraZeneca Chief Executive Pascal Soriot said Summit Therapeutics’ cancer drug could become a foundation for the next generation of combination therapies, underscoring why the Anglo-Swedish drugmaker has committed about $2 billion to the biotech. The comments come as AstraZeneca and Daiichi Sankyo move to test Summit’s ivonescimab alongside Datroway, a sign that large pharmaceutical groups are racing to secure the most promising assets in oncology.

5 min readRead →

Clean Energy & Climate Transition04 Oct 2026, 08:22 AM IST

Poxvirus Study Reveals a Human Gene It Has Kept and Repurposed for Survival

Scientists have identified a poxvirus carrying a stolen human gene and, unusually, showing signs that it has retained and refined the genetic material over time rather than discarding it. The finding offers a rare window into how viruses can borrow from their hosts and adapt those genes for their own biology, with implications for virology, evolutionary research, and the design of future therapeutics.

5 min readRead →

Global Health & BiotechJust now (03:00 PM IST)

Foghorn Cuts 40% of Staff After Lilly Ends Cancer Pact on Data Concerns

Foghorn Therapeutics is laying off about 40% of its workforce after Eli Lilly terminated a cancer drug collaboration that had been a key strategic and financial pillar for the biotech company. The collapse of the partnership, reportedly tied to concerns over data quality, has intensified pressure on Foghorn’s pipeline and sent its shares sharply lower as investors reassess the company’s near-term prospects.

5 min readRead →

Markets, IPOs & Wealth27 Oct 2026, 04:34 PM IST

Tech Is Pushing Healthcare Into a New Investment Cycle

From biosensors and wearables to 3D-printed skin, reconstructed organs and AI-enabled clinical trials, healthcare technology is moving beyond incremental innovation and into a structural shift. The change is reshaping how care is delivered, how drugs are tested and how investors assess the next wave of growth in health-related markets.

4 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Beam Therapeutics:

Washington, D.C.(1)STAT(1)China(1)